IL166343A0 - Igg fc/hiv-gp 120/c3d fusion protein - Google Patents

Igg fc/hiv-gp 120/c3d fusion protein

Info

Publication number
IL166343A0
IL166343A0 IL16634305A IL16634305A IL166343A0 IL 166343 A0 IL166343 A0 IL 166343A0 IL 16634305 A IL16634305 A IL 16634305A IL 16634305 A IL16634305 A IL 16634305A IL 166343 A0 IL166343 A0 IL 166343A0
Authority
IL
Israel
Prior art keywords
hiv
igg
fusion protein
fusion
protein
Prior art date
Application number
IL16634305A
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Publication of IL166343A0 publication Critical patent/IL166343A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16634305A 2002-07-23 2005-01-17 Igg fc/hiv-gp 120/c3d fusion protein IL166343A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39760502P 2002-07-23 2002-07-23
PCT/US2003/022917 WO2004009785A2 (en) 2002-07-23 2003-07-23 IgG Fc/HIV-gp120/C3d FUSION PROTEIN

Publications (1)

Publication Number Publication Date
IL166343A0 true IL166343A0 (en) 2006-01-16

Family

ID=30771086

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16634305A IL166343A0 (en) 2002-07-23 2005-01-17 Igg fc/hiv-gp 120/c3d fusion protein

Country Status (13)

Country Link
US (1) US20060014148A1 (en)
EP (2) EP2374811A1 (en)
JP (2) JP2006509496A (en)
KR (1) KR20050036960A (en)
CN (1) CN100366631C (en)
AU (1) AU2003256671B2 (en)
BR (1) BR0312808A (en)
CA (1) CA2493706A1 (en)
IL (1) IL166343A0 (en)
MX (1) MXPA05000874A (en)
NZ (1) NZ537345A (en)
WO (1) WO2004009785A2 (en)
ZA (1) ZA200410324B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001056355A2 (en) 2000-02-04 2001-08-09 Duke University Human immunodeficiency virus vaccine
US7033593B2 (en) 2000-09-22 2006-04-25 Duke University Immunogen comprising an HIV envelope protein, a ligand and H2 peptide
BR0114094A (en) 2000-09-22 2003-07-22 Univ Duke Immunogen
US7195768B2 (en) 2001-11-07 2007-03-27 Duke University Polyvalent immunogen
US7172761B2 (en) 2001-11-07 2007-02-06 Duke University Polyvalent immunogen
EP1461077A4 (en) 2001-11-07 2006-01-25 Univ Duke Polyvalent immunogen
GB0614780D0 (en) * 2006-07-25 2006-09-06 Ucb Sa Biological products
WO2009137632A2 (en) * 2008-05-06 2009-11-12 Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Hiv immunogen and method of making and using same
WO2010045613A1 (en) * 2008-10-16 2010-04-22 New York Blood Center Immunoenhancer-linked oligomeric hiv vaccines
CA2775564A1 (en) * 2009-10-09 2011-04-14 New York Blood Center, Inc. Immunopotentiator-linked oligomeric influenza immunogenic compositions
WO2011126576A2 (en) * 2010-04-09 2011-10-13 Duke University Genetic signatures in the envelope glycoprotein of hiv-1
CN103037962A (en) 2010-05-24 2013-04-10 独立行政法人农业·食品产业技术综合研究机构 Granulating method and granulating device
KR20140069222A (en) * 2011-09-23 2014-06-09 유니버시티 오브 오슬로 Vaccibodies targeted to cross-presenting dendritic cells
EP2706356A1 (en) * 2012-09-06 2014-03-12 Laboratorios Del. Dr. Esteve, S.A. Methods for identifying HIV neutralizing antibodies
BR112018005931A2 (en) * 2015-09-24 2018-10-09 Abvitro Llc hiv antibody compositions and methods of use
KR20230019227A (en) * 2017-11-17 2023-02-07 그리폴스 다이어그노스틱 솔루션즈 인크. Novel mammalian expressed human immunodeficiency virus envelope protein antigens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
ATE207760T1 (en) * 1993-05-07 2001-11-15 Akzo Nobel Nv HIV IMMUNOGENIC COMPLEXES
BR0114094A (en) 2000-09-22 2003-07-22 Univ Duke Immunogen
EP1461077A4 (en) 2001-11-07 2006-01-25 Univ Duke Polyvalent immunogen

Also Published As

Publication number Publication date
JP2006509496A (en) 2006-03-23
WO2004009785A3 (en) 2004-08-05
AU2003256671A1 (en) 2004-02-09
EP1523492A2 (en) 2005-04-20
AU2003256671B2 (en) 2008-10-16
ZA200410324B (en) 2006-07-26
EP1523492A4 (en) 2006-05-10
CN1668633A (en) 2005-09-14
MXPA05000874A (en) 2005-03-23
CA2493706A1 (en) 2004-01-29
WO2004009785A2 (en) 2004-01-29
KR20050036960A (en) 2005-04-20
NZ537345A (en) 2007-12-21
US20060014148A1 (en) 2006-01-19
JP2010057490A (en) 2010-03-18
BR0312808A (en) 2005-04-19
EP2374811A1 (en) 2011-10-12
CN100366631C (en) 2008-02-06

Similar Documents

Publication Publication Date Title
IL166343A0 (en) Igg fc/hiv-gp 120/c3d fusion protein
IL166751A0 (en) Modified transferin-antibody fusion proteins
EP1463752A4 (en) Albumin fusion proteins
AU2002364586A1 (en) Albumin fusion proteins
EP1594530A4 (en) Albumin fusion proteins
AU2003259294A1 (en) Humanized antibodies against human 4-1bb
PL362324A1 (en) Artificial fusion proteins with reduced immunogenicity
IL202255A0 (en) Binding domain-immunoglobulin fusion proteins
EP1448588A4 (en) Psma antibodies and protein multimers
AU2002307255A1 (en) Vegf fusion proteins
PT1361893E (en) Modified anti-egfr antibodies with reduced immunogenicity
AU2003239365A8 (en) Recombinant glycosyltransferase fusion proteins
ZA200308589B (en) Recombinant fusion proteins and the trimers thereof.
AU2003228364A8 (en) Field-assisted fusion bonding
AU2002332041A1 (en) Albumin fusion proteins
AU2003253621A1 (en) Modified "s" antibodies
HUP0402496A3 (en) Growth hormone fusion protein
AU2002361390A1 (en) Anti-cd7 immunotoxin as fusion protein
GB9913437D0 (en) Fusion proteins
AUPR546801A0 (en) Recombinant antibodies
AU2003226131A8 (en) Novel human cell surface protein with immunoglobulin folds, bgs-19
EP1572092A3 (en) Mk2 interacting proteins
GB0200689D0 (en) Fusion proteins
AU2002361963A1 (en) Fusion proteins containing tlp peptides
GB0213760D0 (en) A fusion protein